Cited by 84Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and SenescenceAging and Gerontology Research

Development of clinical trials to extend healthy lifespan

Open access
Justice, Jamie N., Niedernhofer, Laura, Robbins, Paul D., Aroda, Vanita R., Espeland, Mark A., Kritchevsky, Stephen B., Kuchel, George A., Barzilai, Nir·2018·Cardiovascular Endocrinology & Metabolism

Abstract

Significant progress in defining the biology of aging, particularly in animal models, supports the geroscience hypothesis, which posits that by therapeutically targeting biological aging, the onset of multiple age-related diseases can be delayed ‘en suite’. Geroscience investigators are preparing to test this hypothesis in humans for the first time. In this review, we describe development of large-scale clinical trials designed to determine whether multiple age-related health conditions can be simultaneously alleviated with interventions targeting the underlying biology of aging. We describe the rationale and collaborative, consensus building approach used to design the first aging outcome trial called Targeting Aging with Metformin. Through this case study, we outline features that could be more broadly extended to other geroscience-guided clinical trials, including a process for selecting biochemical and molecular markers of biologic age and we provide a perspective on the potential impact of clinical trials targeting aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/xce.0000000000000159

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical trials using metformin to target ageing have begun.

    “Clinical trials utilizing metformin, which activates AMPK, to target ageing have already begun193.”

    From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [193]

  • It is argued that TAME trial outcomes will give more insight on whether metformin decreases the risk of developing age-dependent diseases, excluding diabetes, in non-diabetic individuals, and potentially provide a tool to target aging itself.

    “It is argued that TAME trial outcomes will give more insight on whether metformin decreases the risk of developing age-dependent diseases, excluding diabetes, in non-diabetic individuals, and potentially provide a tool to target aging itself and not related diseases individually (60, 261).”
  • The TAME trial is a double-blinded, placebo-controlled, multicenter trial planned to involve 14 research centers in the USA and enroll 3000 ethnically diverse, non-diabetic subjects aged 65-80.

    “Targeting Aging with Metformin (TAME) trial is a double-blinded, placebo-controlled, multicenter trial that is planned to involve 14 research centers in the USA, and subject to funding and approval, will enroll 3000 ethnically diverse, non-diabetic subjects aged 65–80 (60, 261).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [2]Services UDoHaH, Prevention CfDCa, Statistics NCfH. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD: National Center for Health Statistics, 2017 Contract No.: DHHS Publication No. 2017–1232. 28910066
  2. [24]Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a Tool to Target Aging. Cell Metab. 2016; 23(6): 1060– 5. Epub June 14, 2016. doi: 10.1016/j.cmet.2016.05.011. 27304507 PMC5943638 · DOI · Paper page

Cited by

Sorted by citations

Authors
Justice, J. N., Niedernhofer, L., Robbins, P. D., Aroda, V. R., Espeland, M. A., Kritchevsky, S. B., Kuchel, G. A., & Barzilai, N.
Affiliations
  • Wake Forest University Health Sciences (US)
  • University of Minnesota (US)
  • Brigham and Women's Hospital (US)
  • Internal Medicine Section on Gerontology and Geriatrics, and the Sticht Center for Healthy Aging and Alzheimer’s Prevention
  • University of Connecticut (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Justice, Jamie N.
Venue
Cardiovascular Endocrinology & Metabolism
Published
2018-12
Volume
7
Issue
4
Pages
80-83
ISSN
2574-0954 (ISSN-L)
OpenAlex
W2911722517
Cited by
84
References
31
Citations by year
2026: 10 · 2025: 6 · 2024: 7 · 2023: 12 · 2022: 16 · 2021: 12 · 2020: 16 · 2019: 5
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (P01AG043376, R01AG052608, R01AG048023, P30AG038072, K01AG059837, U19AG056278, P30AG021332)
  • National Institute of General Medical Sciences (R35GM124922)
  • National Institute of Allergy and Infectious Diseases (R01AI142086)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Aging and Gerontology Research
Keywords
geroscience, healthy lifespan extension, clinical trial design, age-related diseases, biological aging, metformin, consensus building

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review